Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
Michele Stella(University of Catania), Davide Barbagallo(University of Catania), Federica Mirabella(University of Catania), Luca Falzone(University of Catania), Francesco Certo(University of Catania), Rosalia Battaglia(University of Catania), Michele Purrello(University of Catania), Giuseppe Barbagallo(University of Catania), Massimo Libra(University of Catania), Giuseppe Gattuso(University of Catania), Giuseppe Broggi(University of Catania), Rosario Caltabiano(University of Catania), Marco Ragusa(University of Catania), Paolo Musumeci(University of Catania), A Caponnetto(University of Catania), Roberto Altieri(University of Catania), Cinzia Di Pietro(University of Catania), Cristina Barbagallo(University of Catania)
Cited by 108
Related Papers
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508